Have you ever wondered how restaurants achieve such immaculate results with their food? 

Sometimes the food industry has access to tech that can elevate the quality of their meals but now there is a chance for consumers to bring some of those tools into their own kitchens.

From the 2023 Consumer Electronic Show, Typhur's sous vide (which is also a cooking technique in which meats are vacuum sealed and cooked to a perfect temperature) is set to come to market. The latest cooking station has hundreds of recipes and its 12-inch touch screen can also display a step-by-step walkthrough so users can attain that perfect heat.

GE Profile is also set to bring a smart mixer to market that will perfect baking recipes and help bakers avoid mistakes.

Updated January 13, 2023 at 9:06 a.m. ET to correct that Typhur showed off its new sous vide and GE Profile will bring a smart mixer to market.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More